Trade marks
ADDERALL XR®
is a trade-mark used
under licence from Shire US Inc.
FOSRENOL®
is a trade-mark used under
licence from Shire International licensing BV.
MEZAVANT®
is a trade-mark used
under licence from Giuliani International Limited.
ELAPRASE®
is a trade-mark of Shire
Human Genetic Therapies, Inc.
REPLAGAL®
is a trade-mark of Shire
Human Genetic Therapies, Inc.
AGRYLIN®
is a trade-mark used under
licence from Shire US Inc.
ESTRACE®
is a trade-mark used under
licence from Mead Johnson & Company.
ALERTEC®
is a trade-mark used under
licence from Cephalon, Inc.
AMATINE®
is a trade-mark used under
licence from Shire US Inc.
VYVANSE®
is a trade-mark used under
licence from Shire LLC.
DERMAGRAFT®
is a registered
trade-mark used under licence from Shire Regenerative Medicine, Inc.
Please see our Canadian Online
Privacy Policy for more information. While Shire makes reasonable
efforts to include accurate, up-to-date information on the site, Shire makes
no warranties or representations as to its accuracy.